Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9.

In general, inflammatory cells cross basement membranes by producing proteinases. To investigate the role of proteinases in eosinophil basement membrane migration, we studied peripheral blood eosinophils in Matrigel-coated chemotaxis chambers. Electron microscopy showed degradation of the Matrigel layer when eosinophils, added to the upper chamber, transmigrated the membrane in the presence of both platelet-activating factor (PAF) in the lower chamber and interleukin (IL)-5 in both chambers. In the absence of either or both PAF and IL-5, no changes occurred in the Matrigel layer. Matrigel transmigration of eosinophils induced by PAF and IL-5 was inhibited by 1,10-phenanthroline, batimastat, 3,4-dichloroisocoumarin, chymostatin, and a neutralizing antibody for the matrix metalloproteinase (MMP)-9, indicating that serine proteinase(s) and MMP, specifically MMP-9, were involved in the transmigration of eosinophils through Matrigel. In contrast, eosinophil migration through a bare membrane was not affected by batimastat. Using gelatin zymography and immunoblotting, MMP-9 was detected in the migration upper chamber supernatant of the eosinophil transmigration assay and in the conditioned medium of eosinophils. Release of MMP-9 by eosinophils was increased by IL-5, PAF, or both, but the substrate-degrading activity of MMP-9 was increased only in the presence of both IL-5 and PAF, indicating that the releasing and activating mechanisms of MMP-9 are involved in eosinophil basement membrane migration. This study implicates MMP-9 in basement membrane migration of eosinophils and suggests its involvement in inflammatory diseases where tissue eosinophilia plays a role.

[1]  H. Kita,et al.  Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. , 1997, American journal of respiratory cell and molecular biology.

[2]  C. Delacourt,et al.  Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.

[3]  S. Hauser,et al.  Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.

[4]  J. Hogg,et al.  Nonmuscular airway obstruction and asthma. , 1995, American journal of respiratory and critical care medicine.

[5]  E. Waubant,et al.  T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.

[6]  R. Schleimer,et al.  The role of adhesion molecules in human eosinophil and basophil recruitment. , 1994, The Journal of allergy and clinical immunology.

[7]  M. Ebisawa,et al.  Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. , 1994, Journal of immunology.

[8]  J. O'Connell,et al.  Regulation of Matrix Metalloproteinase Activity a , 1994, Annals of the New York Academy of Sciences.

[9]  R. Hoffman,et al.  Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. , 1994, Cancer research.

[10]  N. Katunuma,et al.  Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils. , 1994, Archives of biochemistry and biophysics.

[11]  H. Kita,et al.  CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. , 1994, Journal of immunology.

[12]  W. Parks,et al.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.

[13]  H. Kita,et al.  Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. , 1994, Journal of immunological methods.

[14]  C. Soria,et al.  Activation of the 92 kDa type IV collagenase by tissue kallikrein , 1993, Journal of cellular physiology.

[15]  U. Moll,et al.  Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. , 1993, Hybridoma.

[16]  D. Woolley,et al.  Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. , 1993, Biochemical and biophysical research communications.

[17]  K. Naka,et al.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.

[18]  A. Eisen,et al.  Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. , 1992, The Journal of investigative dermatology.

[19]  P. Jeffery,et al.  Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.

[20]  G Murphy,et al.  A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.

[21]  M. D. de Santi,et al.  Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. , 1992, Archives of biochemistry and biophysics.

[22]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[23]  A. Eisen,et al.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.

[24]  R. Schleimer,et al.  Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. , 1988, Journal of immunology.

[25]  A. Wardlaw,et al.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.

[26]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[27]  H. Sampson,et al.  Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. , 1985, The New England journal of medicine.

[28]  A. Jesaitis,et al.  A continuous, spectroscopic analysis of the kinetics of elastase secretion by neutrophils. The dependence of secretion upon receptor occupancy. , 1982, The Journal of biological chemistry.

[29]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[30]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[31]  McDowell Em,et al.  Histologic fixatives suitable for diagnostic light and electron microscopy. , 1976 .

[32]  A. Spurr A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.